Trial NCT01467505

View at ClinicalTrials.gov 
Org. Study IDs: VX11-950-117

Last trial update was posted on 2015-06-18

MeSH Interventions

Immunosuppressive Agents Interferon alpha-2 Interferon-alpha Interferons Peginterferon alfa-2a Ribavirin

MeSH Conditions

Hepatitis Hepatitis C

Other Conditions


Stopping Reasons

The study was terminated early by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.

Limitations And Caveats

It was decided by Sponsor on 13 January 2014 to terminate the study early at the primary efficacy endpoint (SVR12) as part of a decision to modify the drug development plan. Eligible participants completed virologic follow-up after termination.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID